Fleming, Gini F <br/><br/>
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.  [electronic resource] 

 -  Gynecologic oncology  Mar 2014 
 - 585-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2014.01.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Megestrol Acetate--administration & dosage<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Sirolimus--administration & dosage<br/>Tamoxifen--administration & dosage